Difference between revisions of "Wang M, et al, Cell Res (2020), cited as Ref 80 in DOI:10.1007/s11886-020-01292-3 (Q10589)"
Jump to navigation
Jump to search
(Created claim: DOI Identifier (P138): 10.1038/s41422-020-0282-0, #quickstatements; #temporary_batch_1592505001433) |
(Created claim: PubMed ID (P140): 32020029, #quickstatements; #temporary_batch_1592505101799) |
||
| Property / PubMed ID | |||
| + | |||
| Property / PubMed ID: 32020029 / rank | |||
| + | Normal rank | ||
Revision as of 18:33, 18 June 2020
Cited in: "Cardiovascular Complications in Patients with COVID-19: Consequences of Viral Toxicities and Host Immune Response" Research article published in Curr Cardiol Rep; 2020 04 21 ; 22 (5) 32.
| Language | Label | Description | Also known as |
|---|---|---|---|
| English |
Wang M, et al, Cell Res (2020), cited as Ref 80 in DOI:10.1007/s11886-020-01292-3
|
Cited in: "Cardiovascular Complications in Patients with COVID-19: Consequences of Viral Toxicities and Host Immune Response" Research article published in Curr Cardiol Rep; 2020 04 21 ; 22 (5) 32.
|
Statements
Q10356 (Deleted Item)
0 references
Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro (English)
0 references
Wang M
0 references
Cao R
0 references
Zhang L
0 references
Yang X
0 references
Liu J
0 references
Xu M
0 references
Shi Z
0 references
Hu Z
0 references
Zhong W
0 references
Xiao G
0 references
2020
0 references
